Michael Barbella, Managing Editor04.07.22
HeartBeam Inc. and LIVMOR Inc. are teaming up to improve remote patient monitoring technology.
The two companies are working together to build a HeartBeam branded version of LIVMOR’s Halo+ U.S. Food and Drug Administration (FDA)-cleared turnkey solution for remote patient monitoring (RPM) to connect physicians and patients. Under terms of an agreement forged between the pair, LIVMOR will develop a HeartBeam branded version—the HeartBeam Platform—of the LIVMOR RPM platform customized for HeartBeam products, with senior executives of both companies supervising the project.
“Utilizing LIVMOR’s FDA cleared RPM platform will allow us to meet our schedule for FDA submission of our first product, an easy-to-use heart attack detection software solution for Emergency Department settings,” said Branislav Vajdic, Ph.D., CEO and founder of HeartBeam. “LIVMOR has successfully developed a patient-engaging remote monitoring system of critical physiological biomarkers which we believe can be adapted to utilize with our emergency department software solution for more accurate MI detection. LIVMOR’s experience in the regulatory process is an important benefit, providing support and assistance for us as we seek to submit the HeartBeam Platform for FDA clearance. We look forward to working with the team at LIVMOR to ready our software for submission to the FDA later this year.”
Founded in 2016, LIVMOR is a digital health solutions company developing a patient-engaging remote monitoring system of critical physiological biomarkers. LIVMOR wants to dramatically improve patient outcomes and to significantly reduce healthcare system costs with better quality data for diagnosis and treatment of chronic diseases.
HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting. Its solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution.
The two companies are working together to build a HeartBeam branded version of LIVMOR’s Halo+ U.S. Food and Drug Administration (FDA)-cleared turnkey solution for remote patient monitoring (RPM) to connect physicians and patients. Under terms of an agreement forged between the pair, LIVMOR will develop a HeartBeam branded version—the HeartBeam Platform—of the LIVMOR RPM platform customized for HeartBeam products, with senior executives of both companies supervising the project.
“Utilizing LIVMOR’s FDA cleared RPM platform will allow us to meet our schedule for FDA submission of our first product, an easy-to-use heart attack detection software solution for Emergency Department settings,” said Branislav Vajdic, Ph.D., CEO and founder of HeartBeam. “LIVMOR has successfully developed a patient-engaging remote monitoring system of critical physiological biomarkers which we believe can be adapted to utilize with our emergency department software solution for more accurate MI detection. LIVMOR’s experience in the regulatory process is an important benefit, providing support and assistance for us as we seek to submit the HeartBeam Platform for FDA clearance. We look forward to working with the team at LIVMOR to ready our software for submission to the FDA later this year.”
Founded in 2016, LIVMOR is a digital health solutions company developing a patient-engaging remote monitoring system of critical physiological biomarkers. LIVMOR wants to dramatically improve patient outcomes and to significantly reduce healthcare system costs with better quality data for diagnosis and treatment of chronic diseases.
HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting. Its solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution.